Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers

被引:0
|
作者
Sijbesma, Eline [1 ]
Hallenbeck, Kenneth K. [2 ]
Leysen, Seppe [1 ]
De Vink, Pim J. [1 ]
Skóra, Lukasz [3 ]
Jahnke, Wolfgang [3 ]
Brunsveld, Luc [1 ]
Arkin, Michelle R. [2 ]
Ottmann, Christian [1 ,4 ]
机构
[1] Laboratory of Chemical Biology, Department of Biomedical Engineering, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven,5600 MB, Netherlands
[2] Department of Pharmaceutical Chemistry, Small Molecule Discovery Centre (SMDC), University of California, San Francisco,94143, United States
[3] Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel,CH-4056, Switzerland
[4] Department of Chemistry, University of Duisburg-Essen, Essen,47057, Germany
来源
Journal of the American Chemical Society | 2019年 / 141卷 / 08期
关键词
Breast Cancer - Drug discovery - Estrogen receptor - Fragment-based screenings - Protein-protein interactions - Screening techniques - Small molecules - X ray crystal structures;
D O I
暂无
中图分类号
学科分类号
摘要
Modulation of protein-protein interactions (PPIs) by small molecules has emerged as a valuable approach in drug discovery. Compared to direct inhibition, PPI stabilization is vastly underexplored but has strong advantages, including the ability to gain selectivity by targeting an interface formed only upon association of proteins. Here, we present the application of a site-directed screening technique based on disulfide trapping (tethering) to select for fragments that enhance the affinity between protein partners. We target the phosphorylation-dependent interaction between the hub protein 14-3-3σ and a peptide derived from Estrogen Receptor α (ERα), an important breast cancer target that is negatively regulated by 14-3-3σ. We identify orthosteric stabilizers that increase 14-3-3/ERα affinity up to 40-fold and propose the mechanism of stabilization based on X-ray crystal structures. These fragments already display partial selectivity toward ERα-like motifs over other representative 14-3-3 clients. This first of its kind study illustrates the potential of the tethering approach to overcome the hurdles in systematic PPI stabilizer discovery. © 2019 American Chemical Society.
引用
收藏
页码:3524 / 3531
相关论文
共 50 条
  • [21] Noncellular screening for the discovery of protein-protein interaction modulators
    Kieffer, Charline
    Jourdan, Jean Pierre
    Jouanne, Marie
    Voisin-Chiret, Anne Sophie
    DRUG DISCOVERY TODAY, 2020, 25 (09) : 1592 - 1603
  • [22] Scaling-up a fragment-based protein-protein interaction method using a human reference interaction set
    Schaefer-Ramadan, Stephanie
    Aleksic, Jovana
    Al-Thani, Nayra M.
    Mohamoud, Yasmin A.
    Hill, David E.
    Malek, Joel A.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2022, 90 (04) : 959 - 972
  • [23] Clinical candidates modulating protein-protein interactions: The fragment-based experience
    Valenti, Dario
    Hristeva, Stanimira
    Tzalis, Dimitrios
    Ottmann, Christian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 167 : 76 - 95
  • [24] Fragment-based quantum mechanical calculation of protein-protein binding affinities
    Wang, Yaqian
    Liu, Jinfeng
    Li, Jinjin
    He, Xiao
    JOURNAL OF COMPUTATIONAL CHEMISTRY, 2018, 39 (21) : 1617 - 1628
  • [25] NMR fragment screening: Tackling protein-protein interaction targets
    Schade, M
    Oschkinat, H
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (03) : 365 - 373
  • [26] Estimation of binding parameters for the protein-protein interaction using a site-directed spin labeling and EPR spectroscopy
    Sarewicz, Marcin
    Szytula, Sebastian
    Dutka, Malgorzata
    Osyczka, Artur
    Froncisz, Wojciech
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2008, 37 (04): : 483 - 493
  • [27] Developing Antagonists for the Met-HGF/SF Protein-Protein Interaction Using a Fragment-Based Approach
    Winter, Anja
    Sigurdardottir, Anna G.
    DiCara, Danielle
    Valenti, Giovanni
    Blundell, Tom L.
    Gherardi, Ermanno
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (01) : 3 - 14
  • [28] Fragment-based drug discovery at adaptive protein sites
    Erlanson, Daniel A.
    FASEB JOURNAL, 2007, 21 (05): : A209 - A209
  • [29] Fragment-Based Discovery of Inhibitors of Protein Kinase B
    Davies, Thomas G.
    Woodhead, Steven J.
    Collins, Ian
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (18) : 1705 - 1717
  • [30] Fragment screening for a protein-protein interaction inhibitor to WDR5
    Peat, Thomas S.
    Dennis, Matthew
    Dolezal, Olan
    Newman, Janet
    Morrow, Ben
    Monahan, Brendon
    Foitzik, Richard
    Khoo, Poh Sim
    Stupple, Paul
    Street, Ian
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2018, 74 : A139 - A139